Cargando…
Intervention in COVID-19 linked hypercoaguable states characterized by circuit thrombosis utilizing a direct thrombin inhibitor
• Circuit thrombosis complicates CRRT in COVID-19 despite standard heparin-based anticoagulation regimens. • 5 cases of CRRT thrombosis despite heparin-based anticoagulation resolved using a direct thrombin inhibitor, argatroban. • Changes in fibrinogen levels better reflected response to anticoagul...
Autores principales: | Seshadri, Madhav, Ahamed, Jasimuddin, Laurence, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476895/ http://dx.doi.org/10.1016/j.tru.2020.100009 |
Ejemplares similares
-
COVID-19-ASSOCIATED HYPERCOAGUABLE STATE: A CASE OF ACUTE AORTIC THROMBOSIS
por: Hostetter, Logan, et al.
Publicado: (2020) -
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
por: Ahamed, Jasimuddin, et al.
Publicado: (2022) -
Ximelagatran: Direct Thrombin Inhibitor
por: Ho, Shir-Jing, et al.
Publicado: (2006) -
HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies
por: Laurence, Jeffrey, et al.
Publicado: (2018) -
Baseline characteristics of patients with and without hypercoaguable sepsis and the effect of afelimomab on mortality: a post hoc analysis from the MONARCS trial
por: Panacek, E, et al.
Publicado: (2001)